Illuminating the future of precision cancer surgery with fluorescence imaging and artificial intelligence convergence

Han Cheng1,2,3,4,5, Hongtao Xu1,2,3,4,5, Boyang Peng6

  • 1Department of Oral and Maxillofacial-Head & Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, P. R. China.

NPJ Precision Oncology
|September 9, 2024
PubMed

Insights

Artificial intelligence (AI) combined with near-infrared fluorescence imaging offers improved guidance for tumor resection surgery. This synergy enhances precision cancer surgery, moving innovative techniques closer to clinical practice.

Area of Science:

  • Biomedical Engineering
  • Surgical Oncology
  • Medical Imaging

Background:

  • Near-infrared (NIR) fluorophores have advanced significantly, offering potential for real-time surgical guidance.
  • Fluorescence imaging-guided surgery (FIGS) shows promise but requires further development for widespread clinical adoption.
  • Artificial intelligence (AI) is transforming medicine, with potential applications in enhancing surgical procedures.

Purpose of the Study:

  • To review the principles and clinical evaluations of fluorescence-guided surgery.
  • To explore the integration of AI with fluorescence imaging for improved surgical guidance.
  • To discuss strategies for overcoming challenges in clinical implementation.

Main Methods:

  • Review of current literature on NIR fluorophores and FIGS.
  • Analysis of AI applications in medical imaging and surgical guidance.
  • Discussion of interdisciplinary convergence benefits and implementation strategies.

Main Results:

  • Fluorescence imaging-guided surgery is a promising technique requiring further refinement.
  • AI integration can significantly enhance fluorescence imaging capabilities for surgery.
  • Synergy between AI and FIGS can lead to major innovations in precision cancer surgery.

Conclusions:

  • The convergence of AI and fluorescence imaging holds significant potential for advancing precision cancer surgery.
  • Overcoming technical hurdles is crucial for expediting the clinical application of these technologies.
  • Future research should focus on interdisciplinary collaboration to translate these innovations from bench to bedside.